An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer

被引:76
作者
Maley, Carlo C. [1 ,2 ,3 ]
Koelble, Konrad [4 ,5 ]
Natrajan, Rachael [4 ,6 ]
Aktipis, Athena [1 ,2 ,7 ,8 ]
Yuan, Yinyin [1 ,6 ,9 ]
机构
[1] Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England
[2] Univ Calif San Francisco, Ctr Evolut & Canc, San Francisco, CA 94143 USA
[3] Arizona State Univ, Biodesign Inst, Sch Life Sci, Tempe, AZ USA
[4] Inst Canc Res, Div Breast Canc, London SW3 6JB, England
[5] Royal Marsden Hosp, Dept Histopathol, London SW3 6JJ, England
[6] Inst Canc Res, Div Mol Pathol, London SW3 6JB, England
[7] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA
[8] Arizona State Univ, Biodesign Inst, Ctr Evolut & Med, Tempe, AZ USA
[9] Royal Marsden Hosp, Ctr Mol Pathol, London SW3 6JJ, England
来源
BREAST CANCER RESEARCH | 2015年 / 17卷
基金
英国惠康基金;
关键词
TUMOR-INFILTRATING LYMPHOCYTES; TRASTUZUMAB; PROGRESSION; DIVERSITY; CHEMOTHERAPY; ARCHITECTURE; CARCINOMAS; EVOLUTION; REVEALS;
D O I
10.1186/s13058-015-0638-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Abundance of immune cells has been shown to have prognostic and predictive significance in many tumor types. Beyond abundance, the spatial organization of immune cells in relation to cancer cells may also have significant functional and clinical implications. However there is a lack of systematic methods to quantify spatial associations between immune and cancer cells. Methods: We applied ecological measures of species interactions to digital pathology images for investigating the spatial associations of immune and cancer cells in breast cancer. We used the Morisita-Horn similarity index, an ecological measure of community structure and predator-prey interactions, to quantify the extent to which cancer cells and immune cells colocalize in whole-tumor histology sections. We related this index to disease-specific survival of 486 women with breast cancer and validated our findings in a set of 516 patients from different hospitals. Results: Colocalization of immune cells with cancer cells was significantly associated with a disease-specific survival benefit for all breast cancers combined. In HER2-positive subtypes, the prognostic value of immune-cancer cell colocalization was highly significant and exceeded those of known clinical variables. Furthermore, colocalization was a significant predictive factor for long-term outcome following chemotherapy and radiotherapy in HER2 and Luminal A subtypes, independent of and stronger than all known clinical variables. Conclusions: Our study demonstrates how ecological methods applied to the tumor microenvironment using routine histology can provide reproducible, quantitative biomarkers for identifying high-risk breast cancer patients. We found that the clinical value of immune-cancer interaction patterns is highly subtype-specific but substantial and independent to known clinicopathologic variables that mostly focused on cancer itself. Our approach can be developed into computer-assisted prediction based on histology samples that are already routinely collected.
引用
收藏
页数:13
相关论文
共 40 条
[1]   Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 [J].
Adams, Sylvia ;
Gray, Robert J. ;
Demaria, Sandra ;
Goldstein, Lori ;
Perez, Edith A. ;
Shulman, Lawrence N. ;
Martino, Silvana ;
Wang, Molin ;
Jones, Vicky E. ;
Saphner, Thomas J. ;
Wolff, Antonio C. ;
Wood, William C. ;
Davidson, Nancy E. ;
Sledge, George W. ;
Sparano, Joseph A. ;
Badve, Sunil S. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :2959-+
[2]   Life history trade-offs in cancer evolution [J].
Aktipis, C. Athena ;
Boddy, Amy M. ;
Gatenby, Robert A. ;
Brown, Joel S. ;
Maley, Carlo C. .
NATURE REVIEWS CANCER, 2013, 13 (12) :883-892
[3]   Microenvironmental Independence Associated with Tumor Progression [J].
Anderson, Alexander R. A. ;
Hassanein, Mohamed ;
Branch, Kevin M. ;
Lu, Jenny ;
Lobdell, Nichole A. ;
Maier, Julie ;
Basanta, David ;
Weidow, Brandy ;
Narasanna, Archana ;
Arteaga, Carlos L. ;
Reynolds, Albert B. ;
Quaranta, Vito ;
Estrada, Lourdes ;
Weaver, Alissa M. .
CANCER RESEARCH, 2009, 69 (22) :8797-8806
[4]   Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer [J].
Andre, Fabrice ;
Dieci, Maria V. ;
Dubsky, Peter ;
Sotiriou, Christos ;
Curigliano, Giuseppe ;
Denkert, Carsten ;
Loi, Sherene .
CLINICAL CANCER RESEARCH, 2013, 19 (01) :28-33
[5]   Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer [J].
Anitei, Maria-Gabriela ;
Zeitoun, Guy ;
Mlecnik, Bernhard ;
Marliot, Florence ;
Haicheur, Nacilla ;
Todosi, Ana-Maria ;
Kirilovsky, Amos ;
Lagorce, Christine ;
Bindea, Gabriela ;
Ferariu, Dan ;
Danciu, Mihai ;
Bruneval, Patrick ;
Scripcariu, Viorel ;
Chevallier, Jean-Marc ;
Zinzindohoue, Franck ;
Berger, Anne ;
Galon, Jerome ;
Pages, Franck .
CLINICAL CANCER RESEARCH, 2014, 20 (07) :1891-1899
[6]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[7]   The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups [J].
Curtis, Christina ;
Shah, Sohrab P. ;
Chin, Suet-Feung ;
Turashvili, Gulisa ;
Rueda, Oscar M. ;
Dunning, Mark J. ;
Speed, Doug ;
Lynch, Andy G. ;
Samarajiwa, Shamith ;
Yuan, Yinyin ;
Graef, Stefan ;
Ha, Gavin ;
Haffari, Gholamreza ;
Bashashati, Ali ;
Russell, Roslin ;
McKinney, Steven ;
Langerod, Anita ;
Green, Andrew ;
Provenzano, Elena ;
Wishart, Gordon ;
Pinder, Sarah ;
Watson, Peter ;
Markowetz, Florian ;
Murphy, Leigh ;
Ellis, Ian ;
Purushotham, Arnie ;
Borresen-Dale, Anne-Lise ;
Brenton, James D. ;
Tavare, Simon ;
Caldas, Carlos ;
Aparicio, Samuel .
NATURE, 2012, 486 (7403) :346-352
[8]   Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers [J].
Denkert, Carsten ;
von Minckwitz, Gunter ;
Brase, Jan C. ;
Sinn, Bruno V. ;
Gade, Stephan ;
Kronenwett, Ralf ;
Pfitzner, Berit M. ;
Salat, Christoph ;
Loi, Sherene ;
Schmitt, Wolfgang D. ;
Schem, Christian ;
Fisch, Karin ;
Darb-Esfahani, Silvia ;
Mehta, Keyur ;
Sotiriou, Christos ;
Wienert, Stephan ;
Klare, Peter ;
Andre, Fabrice ;
Klauschen, Frederick ;
Blohmer, Jens-Uwe ;
Krappmann, Kristin ;
Schmidt, Marcus ;
Tesch, Hans ;
Kuemmel, Sherko ;
Sinn, Peter ;
Jackisch, Christian ;
Dietel, Manfred ;
Reimer, Toralf ;
Untch, Michael ;
Loibl, Sibylle .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) :983-991
[9]   Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer [J].
Denkert, Carsten ;
Loibl, Sibylle ;
Noske, Aurelia ;
Roller, Marc ;
Mueller, Berit Maria ;
Komor, Martina ;
Budczies, Jan ;
Darb-Esfahani, Silvia ;
Kronenwett, Ralf ;
Hanusch, Claus ;
von Toerne, Christian ;
Weichert, Wilko ;
Engels, Knut ;
Solbach, Christine ;
Schrader, Iris ;
Dietel, Manfred ;
von Minckwitz, Gunter .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :105-113
[10]   Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift [J].
Formenti, Silvia C. ;
Demaria, Sandra .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (04) :256-265